Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Total Current Liabilities: 2020-2024

Historic Total Current Liabilities for Relay Therapeutics (RLAY) over the last 5 years, with Dec 2024 value amounting to $50.7 million.

  • Relay Therapeutics' Total Current Liabilities fell 30.58% to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.6 million, marking a year-over-year decrease of 30.58%. This contributed to the annual value of $50.7 million for FY2024, which is 67.59% up from last year.
  • According to the latest figures from FY2024, Relay Therapeutics' Total Current Liabilities is $50.7 million, which was up 67.59% from $30.3 million recorded in FY2023.
  • Relay Therapeutics' 5-year Total Current Liabilities high stood at $63.7 million for FY2022, and its period low was $13.6 million during FY2020.
  • Over the past 3 years, Relay Therapeutics' median Total Current Liabilities value was $50.7 million (recorded in 2024), while the average stood at $48.2 million.
  • As far as peak fluctuations go, Relay Therapeutics' Total Current Liabilities skyrocketed by 161.95% in 2022, and later crashed by 52.49% in 2023.
  • Relay Therapeutics' Total Current Liabilities (Yearly) stood at $13.6 million in 2020, then spiked by 78.41% to $24.3 million in 2021, then skyrocketed by 161.95% to $63.7 million in 2022, then crashed by 52.49% to $30.3 million in 2023, then skyrocketed by 67.59% to $50.7 million in 2024.